Artículos de revistas sobre el tema "“don't eat me” signal"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "“don't eat me” signal".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Grimsley, C. "Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals". Trends in Cell Biology 13, n.º 12 (diciembre de 2003): 648–56. http://dx.doi.org/10.1016/j.tcb.2003.10.004.
Texto completoBradley, Conor A. "CD24 — a novel ‘don’t eat me’ signal". Nature Reviews Cancer 19, n.º 10 (12 de agosto de 2019): 541. http://dx.doi.org/10.1038/s41568-019-0193-x.
Texto completoBradley, Conor A. "CD24 — a novel ‘don’t eat me’ signal". Nature Reviews Drug Discovery 18, n.º 10 (21 de agosto de 2019): 747. http://dx.doi.org/10.1038/d41573-019-00146-0.
Texto completoMajeti, R., C. Jamieson, W. W. Pang, S. Jaiswal, N. J. Leeper, G. Wernig y I. L. Weissman. "Clonal Expansion of Stem/Progenitor Cells in Cancer, Fibrotic Diseases, and Atherosclerosis, and CD47 Protection of Pathogenic Cells". Annual Review of Medicine 73, n.º 1 (27 de enero de 2022): 307–20. http://dx.doi.org/10.1146/annurev-med-042420-104436.
Texto completoBrightwell, R. M., K. S. Grzankowski, S. Lele, K. Eng, M. Arshad, H. Chen y K. Odunsi. "The CD47 “don't eat me signal” is highly expressed in human ovarian cancer". Gynecologic Oncology 143, n.º 2 (noviembre de 2016): 393–97. http://dx.doi.org/10.1016/j.ygyno.2016.08.325.
Texto completoFeng, Mingye, James Y. Chen, Rachel Weissman-Tsukamoto, Jens-Peter Volkmer, Po Yi Ho, Kelly M. McKenna, Samuel Cheshier et al. "Macrophages eat cancer cells using their own calreticulin as a guide: Roles of TLR and Btk". Proceedings of the National Academy of Sciences 112, n.º 7 (2 de febrero de 2015): 2145–50. http://dx.doi.org/10.1073/pnas.1424907112.
Texto completoNisha, Sosale y Dennis E. Discher. "How Does CD47-SIRPα ‘Don’t Eat Me Signal’ Physically Signal Self". Blood 122, n.º 21 (15 de noviembre de 2013): 953. http://dx.doi.org/10.1182/blood.v122.21.953.953.
Texto completoPinho, Sandra, Wei Qiaozhi, Maria Maryanovich, Halley Pierce, Fumio Nakahara y Paul S. Frenette. "Vcam1 Is a "Don't-Eat-Me" Signal on Healthy Hematopoietic and Leukemic Stem Cells". Blood 128, n.º 22 (2 de diciembre de 2016): 565. http://dx.doi.org/10.1182/blood.v128.22.565.565.
Texto completoRivest, Serge. "A ‘don’t eat me’ immune signal protects neuronal connections". Nature 563, n.º 7729 (29 de octubre de 2018): 42–43. http://dx.doi.org/10.1038/d41586-018-07165-8.
Texto completoRuss, Atlantis, Anh B. Hua, William R. Montfort, Bushra Rahman, Irbaz Bin Riaz, Muhammad Umar Khalid, Jennifer S. Carew, Steffan T. Nawrocki, Daniel Persky y Faiz Anwer. "Blocking “don't eat me” signal of CD47-SIRPα in hematological malignancies, an in-depth review". Blood Reviews 32, n.º 6 (noviembre de 2018): 480–89. http://dx.doi.org/10.1016/j.blre.2018.04.005.
Texto completoWedekind, Silke. "Refraktäre Lymphome: Neuer Antikörper überwindet das „Don’t-eat-me-Signal“". InFo Hämatologie + Onkologie 22, n.º 9 (septiembre de 2019): 63. http://dx.doi.org/10.1007/s15004-019-6670-2.
Texto completoSun, Jennifer, Barbara Muz, Kinan Alhallak, Matea Markovic, Shannon Gurley, Zhe Wang, Nicole Guenthner et al. "Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma". Cancers 12, n.º 2 (28 de enero de 2020): 305. http://dx.doi.org/10.3390/cancers12020305.
Texto completoMohanty, Suchismita, Maryam Aghighi, Ketan Yerneni, Johanna Lena Theruvath y Heike E. Daldrup‐Link. "Improving the efficacy of osteosarcoma therapy: combining drugs that turn cancer cell ‘don't eat me’ signals off and ‘eat me’ signals on". Molecular Oncology 13, n.º 10 (13 de agosto de 2019): 2049–61. http://dx.doi.org/10.1002/1878-0261.12556.
Texto completoSuresh, Madheswaran, Malarvizhi Gurusamy y Natarajan Sudhakar. "MASKING ANTI-PHAGOCYTIC SIGNAL OF TUMOR BY PRO-PHAGOCYTIC SIGNAL-A KEY TO IMMUREMENT OF CANCER CELL". International Journal of Pharmacy and Pharmaceutical Sciences 8, n.º 9 (1 de septiembre de 2016): 323. http://dx.doi.org/10.22159/ijpps.2016v8i9.12990.
Texto completoAroldi, Andrea, Mario Mauri, Matteo Parma, Elisabetta Terruzzi, Marilena Fedele, Paola Perfetti, Federica Cocito et al. "CD24/Siglec-10 "Don't Eat Me" Signal Blockade Is a Potential Immunotherapeutic Target in Mantle-Cell Lymphoma". Blood 138, Supplement 1 (5 de noviembre de 2021): 2276. http://dx.doi.org/10.1182/blood-2021-154086.
Texto completoKlausz, Katja, Carina Lynn Gehlert, Ammelie Svea Boje, Marta Lustig, Steffen Krohn, Syeda Maliha Ahmed, Christian Kellner et al. "Blocking the Don't Eat Me Signal (CD47-SIRPα Axis) to Improve Antibody-Based Immunotherapy of Multiple Myeloma". Blood 138, Supplement 1 (5 de noviembre de 2021): 2684. http://dx.doi.org/10.1182/blood-2021-152208.
Texto completoWeissman, Irving. "Evolution of normal and neoplastic tissue stem cells: progress after Robert Hooke". Philosophical Transactions of the Royal Society B: Biological Sciences 370, n.º 1680 (19 de octubre de 2015): 20140364. http://dx.doi.org/10.1098/rstb.2014.0364.
Texto completoHawkins, Lois A. y Andrew Devitt. "Current Understanding of the Mechanisms for Clearance of Apoptotic Cells—A Fine Balance". Journal of Cell Death 6 (enero de 2013): JCD.S11037. http://dx.doi.org/10.4137/jcd.s11037.
Texto completoTsuji, Takahiro, Hiroaki Wake, Mariko Shindo, Daisuke Kato, Hiroaki Ozasa y Toyohiro Hirai. "Abstract 3451: Microglial phagocytosis suppressed the development of metastatic tumors in the imaging model of brain metastasis". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 3451. http://dx.doi.org/10.1158/1538-7445.am2022-3451.
Texto completoTheruvath, Johanna, Christopher Mount, Michelle Monje, Crystal Mackall y Robbie Majzner. "IMMU-55. GD2 IS A MACROPHAGE CHECKPOINT MOLECULE AND COMBINED GD2/CD47 BLOCKADE RESULTS IN SYNERGISTIC EFFECTS AGAINST GD2 POSITIVE MALIGNANCIES". Neuro-Oncology 22, Supplement_2 (noviembre de 2020): ii116. http://dx.doi.org/10.1093/neuonc/noaa215.484.
Texto completoSchürch, Christian M., Stefan Forster, Frido Brühl, Sara H. Yang, Emanuela Felley-Bosco y Ekkehard Hewer. "The “don't eat me” signal CD47 is a novel diagnostic biomarker and potential therapeutic target for diffuse malignant mesothelioma". OncoImmunology 7, n.º 1 (21 de septiembre de 2017): e1373235. http://dx.doi.org/10.1080/2162402x.2017.1373235.
Texto completoAroldi, Andrea, Mario Mauri, Matteo Villa, Federica Malighetti, Federica Cocito, Claudia Voena, Roberto Chiarle, Luca Mologni, Rocco Piazza y Carlo Gambacorti-Passerini. "Effects of CD24 "Don't Eat Me" Signal Blockade in Combination with Anti-CD47 and Rituximab in Mantle-Cell Lymphoma". Blood 140, Supplement 1 (15 de noviembre de 2022): 3136–38. http://dx.doi.org/10.1182/blood-2022-159247.
Texto completoElward, K. "“Eat me” and “don't eat me” signals govern the innate immune response and tissue repair in the CNS: emphasis on the critical role of the complement system". Molecular Immunology 40, n.º 2-4 (septiembre de 2003): 85–94. http://dx.doi.org/10.1016/s0161-5890(03)00109-3.
Texto completoAltevogt, Peter, Marei Sammar, Laura Hüser, Viktor Umansky y Jochen Utikal. "Perspective – Escape from destruction: how cancer-derived EVs are protected from phagocytosis". Extracellular vesicles as biomarkers – in pathophysiology, physical education and home office? 2, n.º 1 (2 de septiembre de 2020): 60–64. http://dx.doi.org/10.47184/tev.2020.01.08.
Texto completoLitvack, Michael L. y Nades Palaniyar. "Review: Soluble innate immune pattern-recognition proteins for clearing dying cells and cellular components: implications on exacerbating or resolving inflammation". Innate Immunity 16, n.º 3 (junio de 2010): 191–200. http://dx.doi.org/10.1177/1753425910369271.
Texto completoAtkin-Smith, Georgia K. "Phagocytic clearance of apoptotic, necrotic, necroptotic and pyroptotic cells". Biochemical Society Transactions 49, n.º 2 (12 de abril de 2021): 793–804. http://dx.doi.org/10.1042/bst20200696.
Texto completoMcCracken, Melissa N., Adriel C. Cha y Irving L. Weissman. "Molecular Pathways: Activating T Cells after Cancer Cell Phagocytosis from Blockade of CD47 “Don't Eat Me” Signals". Clinical Cancer Research 21, n.º 16 (26 de junio de 2015): 3597–601. http://dx.doi.org/10.1158/1078-0432.ccr-14-2520.
Texto completoSchürch, C., M. Roelli, M. Wasmer, F. Brühl, S. Forster, R. Maire, S. Di Pancrazio et al. "PO-171 The "don’t eat me" signal CD47 - a therapeutic option in human anaplastic thyroid carcinoma?" Radiotherapy and Oncology 132 (marzo de 2019): 91. http://dx.doi.org/10.1016/s0167-8140(19)30337-8.
Texto completoMaute, Roy Louis, James Y. Chen, Kristopher David Marjon, Jiaqi Duan, Timothy Choi, Mark Chao, Chris H. Takimoto, Balaji Agoram y Jens-Peter Volkmer. "Translational Study of Cell Surface Proteins in Non-Hodgkin Lymphoma Patients Treated with the First-in-Class Anti-CD47 Antibody Magrolimab (5F9) in Combination with Rituximab". Blood 134, Supplement_1 (13 de noviembre de 2019): 5229. http://dx.doi.org/10.1182/blood-2019-127526.
Texto completoNakamura, Kyohei, Mika Casey, Harald Oey, Frank Vari, John Stagg, Maher K. Gandhi y Mark J. Smyth. "Targeting an adenosine-mediated “don’t eat me signal” augments anti-lymphoma immunity by anti-CD20 monoclonal antibody". Leukemia 34, n.º 10 (8 de abril de 2020): 2708–21. http://dx.doi.org/10.1038/s41375-020-0811-3.
Texto completoZuo, Haoxiao, Satwinder Kaur Singh, Marie-José Van Lierop, Jorn Kaspers, Remco Bos, Alwin Kamermans, Helga E. de Vries et al. "219 CD47 and phosphatidylserine contribute to the interaction between antigen presenting cells and the allogeneic cell-based relapse vaccine DCP-001". Journal for ImmunoTherapy of Cancer 9, Suppl 2 (noviembre de 2021): A232. http://dx.doi.org/10.1136/jitc-2021-sitc2021.219.
Texto completoNguyen, Oanh Thi-Kieu, Anh Nguyen Tu Bui, Ngoc Bich Vu y Phuc Van Pham. "ID: 1077 Overexpress of CD47 does not alter stemness of MCF-7 breast cancer cells". Biomedical Research and Therapy 4, S (5 de septiembre de 2017): 163. http://dx.doi.org/10.15419/bmrat.v4is.351.
Texto completoUpton, Rosalynd, Allison Banuelos, Dongdong Feng, Tanuka Biswas, Kevin Kao, Kelly McKenna, Stephen Willingham et al. "Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance". Proceedings of the National Academy of Sciences 118, n.º 29 (13 de julio de 2021): e2026849118. http://dx.doi.org/10.1073/pnas.2026849118.
Texto completoLi, Jingling, Thomas Brickler, Allison Banuelos, Kristopher Marjon, Anna Shcherbina, Sravani Banerjee, Jing Bian, Cyndhavi Narayanan, Irving L. Weissman y Sundari Chetty. "Overexpression of CD47 is associated with brain overgrowth and 16p11.2 deletion syndrome". Proceedings of the National Academy of Sciences 118, n.º 15 (8 de abril de 2021): e2005483118. http://dx.doi.org/10.1073/pnas.2005483118.
Texto completoTal, Michal Caspi, Paige Hansen, Nitya Ramadoss, Regan Volk, Balyn Zaro y Irving L. Weissman. "P66 is a bacterial “don’t eat me signal” that mimics mammalian CD47 and facilitates immune evasion by Borrelia burgdorferi." Journal of Immunology 208, n.º 1_Supplement (1 de mayo de 2022): 163.36. http://dx.doi.org/10.4049/jimmunol.208.supp.163.36.
Texto completoGamboa, Nicholas, Cordell Baker, Osama Youssef y Samuel Cheshier. "IMMU-37. ANTI-CD47 TREATMENT POTENTIATES PHAGOCYTOSIS OF MEDULLOBLASTOMA BY M1 POLARIZED MACROPHAGES FOLLOWING IRRADIATION". Neuro-Oncology 24, Supplement_7 (1 de noviembre de 2022): vii139. http://dx.doi.org/10.1093/neuonc/noac209.534.
Texto completoTian, Lei, Bo Xu, Kun-Yu Teng, Mihae Song, Zheng Zhu, Yuqing Chen, Jing Wang et al. "Targeting Fc Receptor-Mediated Effects and the “Don't Eat Me” Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer". Clinical Cancer Research 28, n.º 1 (13 de octubre de 2021): 201–14. http://dx.doi.org/10.1158/1078-0432.ccr-21-1248.
Texto completoPiao, Longzhu, Susheela Tridandapani y S. Joseph Huang. "Phagocytic activity of macrophages is regulated by first trimester decidual cells in response to pro-inflammatory stimuli via the modulation of “Don't-Eat-Me” signal". Placenta 35, n.º 9 (septiembre de 2014): A57—A58. http://dx.doi.org/10.1016/j.placenta.2014.06.187.
Texto completoAnandan, Vinitha, Thushara Thulaseedharan, Aishwarya Suresh Kumar, Karthika Chandran Latha, Amjesh Revikumar, Ajit Mullasari, Chandrasekharan C. Kartha, Abdul Jaleel y Surya Ramachandran. "Cyclophilin A Impairs Efferocytosis and Accelerates Atherosclerosis by Overexpressing CD 47 and Down-Regulating Calreticulin". Cells 10, n.º 12 (20 de diciembre de 2021): 3598. http://dx.doi.org/10.3390/cells10123598.
Texto completoKazama, Ryo, Hiroaki Miyoshi, Mai Takeuchi, Kohta Miyawaki, Kazutaka Nakashima, Noriaki Yoshida, Keisuke Kawamoto et al. "Combination of CD47 and signal‐regulatory protein‐α constituting the “don’t eat me signal” is a prognostic factor in diffuse large B‐cell lymphoma". Cancer Science 111, n.º 7 (29 de junio de 2020): 2608–19. http://dx.doi.org/10.1111/cas.14437.
Texto completoMelo Garcia, Luciana y Frédéric Barabé. "Harnessing Macrophages through the Blockage of CD47: Implications for Acute Myeloid Leukemia". Cancers 13, n.º 24 (13 de diciembre de 2021): 6258. http://dx.doi.org/10.3390/cancers13246258.
Texto completoCui, Lu, Cristabelle De Souza, Tristan Lerbs, Jessica Poyser, Clarissa Yu, Kerri Rieger, Sally Arai et al. "Multi-Omics Profiling of Skin Biopsies of Patients with Sclerodermatous Graft-Vs-Host Disease Suggests Therapeutic Potential of Targeting Don't Eat Me Signals". Blood 140, Supplement 1 (15 de noviembre de 2022): 272–73. http://dx.doi.org/10.1182/blood-2022-169789.
Texto completoNam, Suk Woo, Sangyean Kim, Min Jeong Na, Eunbi Shin, Jin Woong Ha, Soyoung Jeon y Jeong Hwan Yoon. "Abstract 5165: In vivo therapeutic validation of NRT-YHD_001, a novel macrophage checkpoint inhibitor, in liver cancer". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 5165. http://dx.doi.org/10.1158/1538-7445.am2023-5165.
Texto completoLiu, Mingen, Roddy S. O’Connor, Sophie Trefely, Kathleen Graham, Nathaniel W. Snyder y Gregory L. Beatty. "Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47−mediated ‘don’t-eat-me’ signal". Nature Immunology 20, n.º 3 (21 de enero de 2019): 265–75. http://dx.doi.org/10.1038/s41590-018-0292-y.
Texto completoGriffiths, M. R., P. Gasque y J. W. Neal. "The Regulation of the CNS Innate Immune Response Is Vital for the Restoration of Tissue Homeostasis (Repair) after Acute Brain Injury: A Brief Review". International Journal of Inflammation 2010 (2010): 1–18. http://dx.doi.org/10.4061/2010/151097.
Texto completoHan, Xiao, Mengning Wang, Songwei Duan, Paul J. Franco, Jennifer Hyoje-Ryu Kenty, Preston Hedrick, Yulei Xia et al. "Generation of hypoimmunogenic human pluripotent stem cells". Proceedings of the National Academy of Sciences 116, n.º 21 (30 de abril de 2019): 10441–46. http://dx.doi.org/10.1073/pnas.1902566116.
Texto completoAstle, John, Yangfei Xiang, Anthony Rongvaux, Carla Weibel, Henchey Elizabeth, Stephanie Halene, In-Hyun Park y Richard Flavell. "Developing a Model of Human Pluripotent to Hematopoietic Stem Cell Development in Mistrg Mice". Blood 126, n.º 23 (3 de diciembre de 2015): 4755. http://dx.doi.org/10.1182/blood.v126.23.4755.4755.
Texto completoYsebaert, Loic, Emilie Laprevotte, Christian Klein, Guy Laurent, Anne Quillet-Mary, Mary Poupot y Jean-Jacques Fournié. "“Don't Eat me”: CD47 and LFA-1 Modulate CLL Response to Nurselike Cells-Mediated Antibody-Dependent Phagocytosis Induced by Rituximab and Obinutuzumab (GA101)". Blood 118, n.º 21 (18 de noviembre de 2011): 1762. http://dx.doi.org/10.1182/blood.v118.21.1762.1762.
Texto completoMitra, Siddhartha, Daniel Picard, Nan Qin, Allison Cole, Joselyn Cruz Cruz, Viktoria Marquardt, Sujatha Venkataraman, Rajeev Vibhakar y Marc Remke. "IMMU-38. MYC DRIVEN IMMUNE SUPPRESSION IN GROUP 3 MEDULLOBLASTOMA". Neuro-Oncology 24, Supplement_7 (1 de noviembre de 2022): vii139. http://dx.doi.org/10.1093/neuonc/noac209.535.
Texto completoAndrejeva, Gabriela, Benjamin Capoccia, Rachel Delston, Michael Donio, Ronald Hiebsch, Robyn Puro, Casey Wilson, Arun Kashyap y Daniel Pereira. "260 CD47 antibody, AO-176 demonstrates potent anti-tumor activity in pre-clinical solid tumor xenografts as a single agent and in combination with multiple classes of therapeutics". Journal for ImmunoTherapy of Cancer 9, Suppl 2 (noviembre de 2021): A282. http://dx.doi.org/10.1136/jitc-2021-sitc2021.260.
Texto completo